Description

IDEX Corporation (IEX): Why Exposure to Water, Life Sciences & Semiconductors Matters Right Now!

IDEX Corporation’s recent financial performance and strategic outlook present a multi-faceted picture for investors. In the fourth quarter of 2025, IDEX exhibited signs of solid growth with organic sales increasing across its portfolio. The company achieved a notable 34% organic order growth in its Health & Science Technologies (HST) segment, driven by strong demand in data center construction, semiconductor filtration, and space and defense markets. Despite facing challenges in some sectors, such as industrial and automotive markets which remained flat, IDEX managed to expand its order book considerably within HST, suggesting that the company’s strategic pivot to targeted advantage markets is gaining traction. Financially, the company reported a modest 1% organic revenue growth for the quarter, with its HST segment leading the charge with a 5% increase in organic sales.